Baş Ağrısı Tedavisinde Beslenme Yaklaşımı
Özet
Baş ağrısı ve migren tedavisinde beslenme yaklaşımları, tetikleyici ve önleyici gıdalar ile bağırsak-beyin ekseni çerçevesinde ele alınmaktadır. Primer ve sekonder olarak sınıflandırılan baş ağrılarının, gıdalar tarafından serebral glukoz metabolizması, nitrik oksit salınımı ve inflamasyon gibi mekanizmalarla tetiklendiği düşünülmektedir. Çikolata, kafein, monosodyum glutamat, histamin ve tiramin gibi biyolojik aminler, alkol, yapay tatlandırıcılar, nitritler ve glüten en sık bildirilen diyet tetikleyicileridir. Buna karşılık, antiinflamatuar özellikli Akdeniz diyeti nörojenik inflamasyonu azaltarak baş ağrısını önlemede etkili bir rol oynamaktadır. Tetikleyicilerin dışlandığı eliminasyon diyetleri ve karbonhidratı kısıtlayan ketojenik diyetlerin de ağrı sıklığını azalttığı gösterilmiştir. Ayrıca DNA metilasyonunu hedefleyen folat, B6 ve B12 vitaminlerini içeren epigenetik diyetlerin yanı sıra magnezyum, omega-3 ve D vitamini gibi nutrasötiklerin baş ağrısı şiddetini azalttığı kanıtlanmıştır. Son olarak, artan bağırsak geçirgenliği ve mikrobiyata profilinin trigeminovasküler sistemi etkileyerek migreni tetikleyebildiği, probiyotik takviyelerinin ise nöroinflamasyonu hafifletebildiği saptanmıştır. Sonuç olarak, beslenme düzeninin hekim rehberliğinde kişiselleştirilmesi tedavi başarısı için elzemdir.
Nutritional approaches in the treatment of headache and migraine are evaluated within the framework of triggering and preventive foods as well as the gut-brain axis. Headaches, classified as primary and secondary, are thought to be triggered by foods through mechanisms such as cerebral glucose metabolism, nitric oxide release, and inflammation. Chocolate, caffeine, monosodium glutamate, biological amines like histamine and tyramine, alcohol, artificial sweeteners, nitrites, and gluten are the most commonly reported dietary triggers. Conversely, the anti-inflammatory Mediterranean diet plays an effective role in preventing headaches by reducing neurogenic inflammation. Elimination diets that exclude triggers and carbohydrate-restricting ketogenic diets have also been shown to reduce pain frequency. Additionally, epigenetic diets containing folate, vitamins B6 and B12 that target DNA methylation, along with nutraceuticals such as magnesium, omega-3, and vitamin D, have been proven to decrease headache severity. Finally, it has been determined that increased intestinal permeability and the microbiota profile can trigger migraine by affecting the trigeminovascular system, whereas probiotic supplements can alleviate neuroinflammation. Consequently, personalizing dietary patterns under medical guidance is essential for treatment success.
Referanslar
Headache Classification Committee of the International Headache Society . The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1–211
Saracco, M. G., Calabrese, G., Cavallini, M., Montano, V., Rinaldi, B., Valfrè, W., & Aguggia, M. (2014). Relationship between primary headache and nutrition: a questionnaire about dietary habits of patients with headache. Neurological Sciences, 35(1), 159-161.
Martin, V. T., & Vij, B. (2016). Diet and headache: part 2. Headache: The Journal of Head and Face Pain, 56(9), 1553-1562.
Martin, V. T., & Vij, B. (2016). Diet and headache: part 1. Headache: The Journal of Head and Face Pain, 56(9), 1543-1552.
Kanar, H. S., Toz, H. T., & Penbe, A. (2021). Comparison of retinal nerve fiber layer, macular ganglion cell complex and choroidal thickness in patients with migraine with and without aura by using optical coherence tomography. Photodiagnosis and Photodynamic Therapy, 34, 102323.Cairns, B. E. (2016). Influence of pro-algesic foods on chronic pain conditions. Expert review of neurotherapeutics, 16(4), 415-423.
Karsan, N., & Goadsby, P. J. (2018). Biological insights from the premonitory symptoms of migraine. Nature Reviews Neurology, 14(12), 699-710.
Lisicki, M., & Schoenen, J. (2021). Old Habits Die Hard: Dietary Habits of Migraine Patients Challenge our Understanding of Dietary Triggers. Frontiers in neurology, 12, 748419-748419.
Lacerenza, M. R., Schoss, F., & Grazzi, L. (2015). The multimodal treatment in headaches. The journal of headache and pain, 16(1), 1-2.
Chai, N. C., Bond, D. S., Moghekar, A., Scher, A. I., & Peterlin, B. L. (2014). Obesity and headache: Part II–potential mechanism and treatment considerations. Headache: The Journal of Head and Face Pain, 54(3), 459-471.
Tilg, H., & Moschen, A. R. (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology, 6(10), 772-783.
Peterlin, B. L., Sacco, S., Bernecker, C., & Scher, A. I. (2016). Adipokines and migraine: a systematic review. Headache: The Journal of Head and Face Pain, 56(4), 622-644.
Bond, D. S., Vithiananthan, S., Nash, J. M., Thomas, J. G., & Wing, R. R. (2011). Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology, 76(13), 1135-1138.
Novack, V., Fuchs, L., Lantsberg, L., Kama, S., Lahoud, U., Horev, A., ... & Ifergane, G. (2011). Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia, 31(13), 1336-1342.
Rainero, I., Govone, F., Gai, A., Vacca, A., & Rubino, E. (2018). Is migraine primarily a metaboloendocrine disorder?. Current pain and headache reports, 22(5), 1-9.
Ren, C., Liu, J., Zhou, J., Liang, H., Wang, Y., Sun, Y., ... & Yin, Y. (2018). Low levels of serum serotonin and amino acids identified in migraine patients. Biochemical and biophysical research communications, 496(2), 267-273.
Sarchielli, P., Rainero, I., Coppola, F., Rossi, C., Mancini, M. L., Pinessi, L., & Calabresi, P. (2008). Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Cephalalgia, 28(7), 714-722.
Rasmussen, B. K., Jensen, R., Schroll, M., & Olesen, J. (1991). Epidemiology of headache in a general population—a prevalence study. Journal of clinical epidemiology, 44(11), 1147-1157.
Olesen, J., Burstein, R., Ashina, M., & Tfelt-Hansen, P. (2009). Origin of pain in migraine: evidence for peripheral sensitisation. The Lancet Neurology, 8(7), 679-690.
Hardy, T. M., & Tollefsbol, T. O. (2011). Epigenetic diet: impact on the epigenome and cancer. Epigenomics, 3(4), 503-518.
Kanwal, R., & Gupta, S. (2012). Epigenetic modifications in cancer. Clinical genetics, 81(4), 303-311.
Gazerani, P., & Vinterhøj, H. S. H. (2016). ‘Omics’: an emerging field in pain research and management. Future Neurology, 11(4), 255-265.
Gazerani, P. (2019). Current evidence on potential uses of MicroRNA biomarkers for migraine: from diagnosis to treatment. Molecular diagnosis & therapy, 23(6), 681-694.
Fila, M., Pawłowska, E., & Blasiak, J. (2019). Mitochondria in migraine pathophysiology–does epigenetics play a role?. Archives of medical science: AMS, 15(4), 944.
Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R. F. (2019). Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. Journal of neuroinflammation, 16(1), 1-14.
Cussotto, S., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2018). The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective. Frontiers in neuroendocrinology, 51, 80-101.
Gazerani, P. (2019). Probiotics for Parkinson’s disease. International journal of molecular sciences, 20(17), 4121.
Tai, M. L. S., Yap, J. F., & Goh, C. B. (2018). Dietary trigger factors of migraine and tension-type headache in a South East Asian country. Journal of pain research, 11, 1255.
Hoffmann, J., & Recober, A. (2013). Migraine and triggers: post hoc ergo propter hoc?. Current pain and headache reports, 17(10), 1-7.
Park, J. W., Chu, M. K., Kim, J. M., Park, S. G., & Cho, S. J. (2016). Analysis of trigger factors in episodic migraineurs using a smartphone headache diary applications. PloS one, 11(2), e0149577.
Marcus, D. A., Scharff, L., Turk, D., & Gourley, L. M. (1997). A double‐blind provocative study chocolate as a trigger of headache. Cephalalgia, 17(8), 855-862.
Nehlig, A. (2016). Effects of coffee/caffeine on brain health and disease: What should I tell my patients?. Practical neurology, 16(2), 89-95.
Alsene, K., Deckert, J., Sand, P., & de Wit, H. (2003). Association between A 2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology, 28(9), 1694-1702.
Elkind, A. (2005). Acetaminophen, Aspirin, and Caffeine Versus Sumatriptan Succinate in the Early Treatment of Migraine: Results Fr... Headache, 45, 973-982.
Scopp, A. L. (1991). MSG and hydrolyzed vegetable protein induced headache: review and case studies. Headache: The Journal of Head and Face Pain, 31(2), 107-110.
Kwok, R. H. (1968). Chinese-restaurant syndrome. The New England journal of medicine, 278(14), 796-796.
Maintz, L., & Novak, N. (2007). Histamine and histamine intolerance. The American journal of clinical nutrition, 85(5), 1185-1196.
Wantke, F., Götz, M., & Jarisch, R. (1994). The red wine provocation test: intolerance to histamine as a model for food intolerance. In Allergy and Asthma Proceedings (Vol. 15, No. 1, p. 27). OceanSide Publications.
Mušič, E., Korošec, P., Šilar, M., Adamič, K., Košnik, M., & Rijavec, M. (2013). Serum diamine oxidase activity as a diagnostic test for histamine intolerance. Wiener Klinische Wochenschrift, 125(9), 239-243.
Manzotti, G., Breda, D., Di Gioacchino, M., & Burastero, S. (2016). Serum diamine oxidase activity in patients with histamine intolerance. International journal of immunopathology and pharmacology, 29(1), 105-111.
Izquierdo, J., Mon, D., Lorente, M., & Singla, L. S. (2013). A randomized doubled blinded trial of treatment with diamino-oxidase (DAO) in patients with migraine and deficit of enzyme'/INS; s activity. Journal of the Neurological Sciences, 333, e505-e506.
Blackwell, B. (1963). Hypertensive crisis due to monoamine-oxidase inhibitors. The Lancet, 282(7313), 849-851.
Kelman, L. (2007). The triggers or precipitants of the acute migraine attack. Cephalalgia, 27(5), 394-402.
Littlewood, J., Glover, V., Davies, P. T. G., Gibb, C., Sandler, M., & Rose, F. C. (1988). Red wine as a cause of migraine. The Lancet, 331(8585), 558-559.
Koehler, S. M., & Glaros, A. (1988). The effect of aspartame on migraine headache. Headache: The Journal of Head and Face Pain, 28(1), 10-14.
Bigal, M. E., & Krymchantowski, A. V. (2006). Migraine triggered by sucralose—a case report. Headache: The Journal of Head and Face Pain, 46(3), 515-517.
Peris, F., Donoghue, S., Torres, F., Mian, A., & Wöber, C. (2017). Towards improved migraine management: Determining potential trigger factors in individual patients. Cephalalgia, 37(5), 452-463.
Gabrielli, M., Cremonini, F., Fiore, G., Addolorato, G., Padalino, C., Candelli, M., ... & Pola, P. (2003). Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study. The American journal of gastroenterology, 98(3), 625-629.
Hadjivassiliou, M., Sanders, D. S., Grünewald, R. A., Woodroofe, N., Boscolo, S., & Aeschlimann, D. (2010). Gluten sensitivity: from gut to brain. The Lancet Neurology, 9(3), 318-330.
Martin, V. T., & Vij, B. (2016). Diet and headache: part 2. Headache: The Journal of Head and Face Pain, 56(9), 1553-1562.
Arab, A., Khorvash, F., Karimi, E., Heidari, Z., & Askari, G. (2021). The effects of the dietary approaches to stop hypertension (DASH) diet on oxidative stress and clinical indices of migraine patients: a randomized controlled trial. Nutritional Neuroscience, 1-10.
Hindiyeh, N. A., Zhang, N., Farrar, M., Banerjee, P., Lombard, L., & Aurora, S. K. (2020). The role of diet and nutrition in migraine triggers and treatment: a systematic literature review. Headache: The Journal of Head and Face Pain, 60(7), 1300-1316.
Evcili, G., Utku, U., Ogun, M. N., & Ozdemir, G. (2018). Early and long period follow-up results of low glycemic index diet for migraine prophylaxis. Agri, 30(1), 8-11.
Geppetti, P., Capone, J. G., Trevisani, M., Nicoletti, P., Zagli, G., & Tola, M. R. (2005). CGRP and migraine: neurogenic inflammation revisited. The journal of headache and pain, 6(2), 61-70.
Arab, A., Khorvash, F., Karimi, E., Hadi, A., & Askari, G. (2021). Associations between adherence to Mediterranean dietary pattern and frequency, duration, and severity of migraine headache: A cross-sectional study. Nutritional Neuroscience, 1-10.
Bakırhan, H., Yıldıran, H., & Uyar Cankay, T. (2021). Associations between diet quality, DASH and Mediterranean dietary patterns and migraine characteristics. Nutritional Neuroscience, 1-11.
Alpay, K., Ertaş, M., Orhan, E. K., Üstay, D. K., Lieners, C., & Baykan, B. (2010). Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia, 30(7), 829-837.
Aydinlar, E. I., Dikmen, P. Y., Tiftikci, A., Saruc, M., Aksu, M., Gunsoy, H. G., & Tozun, N. (2013). IgG‐based elimination diet in migraine plus irritable bowel syndrome. Headache: The Journal of Head and Face Pain, 53(3), 514-525.
Cairns, B. E. (2016). Influence of pro-algesic foods on chronic pain conditions. Expert review of neurotherapeutics, 16(4), 415-423.
Paoli, A. (2014). Ketogenic diet for obesity: friend or foe?. International journal of environmental research and public health, 11(2), 2092-2107.
Di Lorenzo, C., Coppola, G., Sirianni, G., Di Lorenzo, G., Bracaglia, M., Di Lenola, D., ... & Pierelli, F. (2015). Migraine improvement during short lasting ketogenesis: a proof‐of‐concept study. European journal of neurology, 22(1), 170-177.
Harrington, M. G., Fonteh, A. N., Arakaki, X., Cowan, R. P., Ecke, L. E., Foster, H., ... & Biringer, R. G. (2010). Capillary endothelial Na+, K+, ATPase transporter homeostasis and a new theory for migraine pathophysiology. Headache: The Journal of Head and Face Pain, 50(3), 459-478.
Harrington, M. G., Fonteh, A. N., Cowan, R. P., Perrine, K., Pogoda, J. M., Biringer, R. G., & Hühmer, A. F. (2006). Cerebrospinal fluid sodium increases in migraine. Headache: The Journal of Head and Face Pain, 46(7), 1128-1135.
Pogoda, J. M., Gross, N. B., Arakaki, X., Fonteh, A. N., Cowan, R. P., & Harrington, M. G. (2016). Severe headache or migraine history is inversely correlated with dietary sodium intake: NHANES 1999–2004. Headache: The Journal of Head and Face Pain, 56(4), 688-698.
Gazerani, P. (2020). Migraine and diet. Nutrients, 12(6), 1658.
Fila, M., Chojnacki, C., Chojnacki, J., & Blasiak, J. (2019). Is an “Epigenetic Diet” for Migraines Justified? The Case of Folate and DNA Methylation. Nutrients, 11(11), 2763.
Miya Shaik, M., Lin Tan, H., A Kamal, M., & Hua Gan, S. (2014). Do folate, vitamins B6 and B12 play a role in the pathogenesis of migraine? The role of pharmacoepigenomics. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 13(5), 828-835.
Meijers, J. M., Schols, J. M., Soeters, P. B., & Halfens, R. J. (2010). Defining malnutrition: mission or mission impossible?. Nutrition, 26(4), 432-440.
Brower, V. (1998). Nutraceuticals: poised for a healthy slice of the healthcare market?. Nature biotechnology, 16(8), 728-731.
Kalra, E. K. (2003). Nutraceutical-definition and introduction. Aaps Pharmsci, 5(3), 27-28.
Taylor, F. R. (2011). Nutraceuticals and headache: the biological basis. Headache: the journal of head and face pain, 51(3), 484-501.
Samaan, Z., Gaysina, D., Cohen-Woods, S., Craddock, N., Jones, L., Korszun, A., ... & Farmer, A. (2011). Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC neurology, 11(1), 1-9.
Menon, S., Lea, R. A., Roy, B., Hanna, M., Wee, S., Haupt, L. M., ... & Griffiths, L. R. (2012). Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation. Pharmacogenetics and genomics, 22(10), 741-749.
Lea, R., Colson, N., Quinlan, S., Macmillan, J., & Griffiths, L. (2009). The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenetics and genomics, 19(6), 422-428.
Menon, S., Nasir, B., Avgan, N., Ghassabian, S., Oliver, C., Lea, R., ... & Griffiths, L. (2016). The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients. The journal of headache and pain, 17(1), 1-7.
Knutsen, K. V., Brekke, M., Gjelstad, S., & Lagerløv, P. (2010). Vitamin D status in patients with musculoskeletal pain, fatigue and headache: a cross-sectional descriptive study in a multi-ethnic general practice in Norway. Scandinavian journal of primary health care, 28(3), 166-171.
Prakash, S., Makwana, P., & Rathore, C. (2016). Vitamin D deficiency mimicking chronic tension-type headache in children. Case Reports, 2016, bcr2015213833.
Prakash, S., Kumar, M., Belani, P., Susvirkar, A., & Ahuja, S. (2013). Interrelationships between chronic tension-type headache, musculoskeletal pain, and vitamin D deficiency: Is osteomalacia responsible for both headache and musculoskeletal pain?. Annals of Indian Academy of Neurology, 16(4), 650.
Sadeghi, O., Maghsoudi, Z., Khorvash, F., Ghiasvand, R., & Askari, G. (2015). The relationship between different fatty acids intake and frequency of migraine attacks. Iranian Journal of Nursing and Midwifery Research, 20(3), 334.
Pradalier, A., Bakouche, P., Baudesson, G., Delage, A., Cornaille-Lafage, G., Launay, J. M., & Biason, P. (2001). Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia, 21(8), 818-822.
Rybicka, M., Baranowska-Bosiacka, I., Zyluk, B., Nowacki, P., & Chlubek, D. (2012). The role of magnesium in migraine pathogenesis. Potential use of magnesium compounds in prevention and treatment of migraine headaches. Journal of Elementology, 17(2).
Cady, R.J.; Durham, P.L. Cocoa-enriched diets enhance expression of phosphatases and decrease expression of inflammatory molecules in trigeminal ganglion neurons. Brain Res. 2010, 1323, 18–32
Slavin, M., Bourguignon, J., Jackson, K., & Orciga, M. A. (2016). Impact of Food Components on in vitro Calcitonin Gene-Related Peptide Secretion—A Potential Mechanism for Dietary Influence on Migraine. Nutrients, 8(7), 406.
Cady, R. J., Hirst, J. J., & Durham, P. L. (2010). Dietary grape seed polyphenols repress neuron and glia activation in trigeminal ganglion and trigeminal nucleus caudalis. Molecular pain, 6, 1744-8069.
Orr, S. L. (2016). Diet and nutraceutical interventions for headache management: a review of the evidence. Cephalalgia, 36(12), 1112-1133.
Orr, S. L., Friedman, B. W., Christie, S., Minen, M. T., Bamford, C., Kelley, N. E., & Tepper, D. (2016). Management of adults with acute migraine in the emergency department: the American Headache Society evidence assessment of parenteral pharmacotherapies. Headache: The Journal of Head and Face Pain, 56(6), 911-940.
Galland, L. (2014). The gut microbiome and the brain. Journal of medicinal food, 17(12), 1261-1272.
Arzani, M., Jahromi, S. R., Ghorbani, Z., Vahabizad, F., Martelletti, P., Ghaemi, A., ... & Togha, M. (2020). Gut-brain Axis and migraine headache: a comprehensive review. The journal of headache and pain, 21(1), 1-12.
Hiippala, K., Jouhten, H., Ronkainen, A., Hartikainen, A., Kainulainen, V., Jalanka, J., & Satokari, R. (2018). The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation. Nutrients, 10(8), 988.
Bond, D. S., Vithiananthan, S., Nash, J. M., Thomas, J. G., & Wing, R. R. (2011). Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology, 76(13), 1135-1138.
Kang, L., Tang, W., Zhang, Y., Zhang, M., Liu, J., Li, Y., ... & Yu, S. (2021). The gut microbiome modulates nitroglycerin-induced migraine-related hyperalgesia in mice. Cephalalgia, 03331024211050036.
Martami, F., Togha, M., Seifishahpar, M., Ghorbani, Z., Ansari, H., Karimi, T., & Jahromi, S. R. (2019). The effects of a multispecies probiotic supplement on inflammatory markers and episodic and chronic migraine characteristics: A randomized double-blind controlled trial. Cephalalgia, 39(7), 841-853.
